Document is current
Any future updates will be listed below
-
Authors
Yan, Yang https://orcid.org/0000-0001-7167-0261
Zhao, Changying
Niu, Jialan
Yan, Pengyun
Li, Jing
Wang, Duolao
Li, Guoliang
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct06141525 at ClinicalTrials.govDocuments that mention this clinical trial
Rationale and Design of the IMPROVE Trial: A Multicenter, Randomized, Controlled, Open-label, Blinded-endpoint Trial Assessing the Efficacy of Remote Ischemic Conditioning in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting
https://doi.org/10.1007/s12325-024-02836-7
-
Funding
Funding for this research was provided by:
Clinical Research Award of The First Affiliated Hospital of Xi'an Jiaotong University (XJTU1AF2021CRF-005)
- License Information
-
More Information
Article History
Received: 2 December 2023
Accepted: 7 March 2024
First Online: 15 April 2024
Declarations
:
: Yang Yan, Changying Zhao, Jialan Niu, Pengyun Yan, Jing Li, Duolao Wang and Guoliang Li have nothing to disclose.
: This study complied with the Declaration of Helsinki and was approved by the Ethics Committee of The First Affiliated Hospital of Xi’an Jiaotong University (No. XJTU1AF2022LSK-427) and has been registered in the ClinicalTrials.gov (NCT06141525). Prior to enrolment, participants are required to sign an informed consent form on a voluntary basis.
